1. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805.
https://doi.org/10.1056/NEJMra064398
.
2. Jefferson AJ, Thurman JM, Schrier RW. Pathophysiology and etiology of acute kidney injury. In: Johnson RJ, Feehally J, Floege J, Tonelli M, editors. Comprehensive clinical nephrology. 6th ed. Amsterdam: Elsevier; 2018. p. 797–812.
3. Chan L, Chittinandana A, Shapiro JI, et al. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Phys. 1994;266:F135–8.
https://doi.org/10.1152/ajprenal.1994.266.1.F135
.
4. Jerkić M, Miloradović Z, Jovović D, et al. Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure. Nephrol Dial Transplant. 2004;19:83–94.
5. Badr KF, Kelley VE, Rennke HG, Brenner BM. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int. 1986;30:474–80.